BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.3//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Thursday\, April 10\, 202512:00pm - 1:00pmHybrid Attendance: Re
 search Bldg. 6\, 1.206 Auditoriumor Zoomhttps://www.zoomgov.com/s/16090392
 03?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06tyb2.1passcode: 089555&nbsp\;Guest Presen
 terDavid A. Khan\, MDProfessor of Medicine and PediatricsAllergy &amp\; Im
 munology Program Director&ldquo\;What&rsquo\;s New in Antibiotic Allergies
 ?&rdquo\;Objectives: At this conclusion of this presentation\, participant
 s should be able to:Understand the morbidity associated with a penicillin 
 allergy label.Understand the low cross-reactivity amongst beta-lactam anti
 biotics.Be able to identify patients who are low risk\, and would be amena
 ble to antibiotic delabeling.&nbsp\;Target Audience and Needs: Internal Me
 dicine faculty\, staff\, registered nurses\, residents\, fellows\, student
 s\, and internists specializing in Allergy &amp\; Immunology\, Cardiology\
 , Endocrinology\, Gastroenterology\, General Medicine\,\n    Geriatrics\, 
 Hematology &amp\; Oncology\, Infectious Diseases\, Nephrology\, Palliative
  Care\, Pulmonary Critical Care &amp\; Sleep Medicine\, and Rheumatology n
 eed to be regularly updated with new research and guidelines regarding the
  evaluation\n    and management of medical disorders and implement them in
  clinical practice to enhance the quality of patient care and improve pati
 ent outcomes.Educational Methods: Educational methods will include lecture
 s\, case presentations\, literature review\, and panel discussion.Activity
  Evaluation: Participants may be asked to complete a session evaluation.Fi
 nancial Disclosure: The following are reports of relationships with commer
 cial interests by those individuals who are in the position to control the
  content of this activity.Dr. Khan does not have any financial disclosures
  to provide.&nbsp\;Accreditation/Credit Designation: The University of Tex
 as Medical Branch is accredited by the Accreditation Council for Continuin
 g Medical Education (ACCME) to provide continuing medical education for ph
 ysicians.The University of Texas Medical Branch designates this live activ
 ity for a maximum of _1_ AMA PRA Category 1 Credits&trade\;. Physicians sh
 ould claim only the credit commensurate with the extent of their participa
 tion in the activity.&nbsp\;
DTEND:20250410T180000Z
DTSTAMP:20260517T124541Z
DTSTART:20250410T170000Z
LOCATION:
SEQUENCE:0
SUMMARY:Grand Rounds - 04/10/2025
UID:RFCALITEM639146007411061389
X-ALT-DESC;FMTTYPE=text/html:<p style="text-align:center\;"><strong>Thursda
 y\, April 10\, 2025</strong><br /><strong>12:00pm - 1:00pm</strong><br /><
 br /><strong style="color:#da1f12\;">Hybrid Attendance: Research Bldg. 6\,
  1.206 Auditorium<br />or </strong><br /><strong style="color:#da1f12\;">Z
 oom</strong><strong><br /></strong></p><p style="text-align:center\;"><a h
 ref="https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06ty
 b2.1">https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06t
 yb2.1</a></p><p style="text-align:center\;">passcode: 089555</p><p style="
 text-align:center\;"><strong>&nbsp\;</strong></p><p style="text-align:cent
 er\;"><strong>Guest Presenter</strong></p><p style="text-align:center\;fon
 t-size:large\;"><strong>David A. Khan\, MD</strong><br /><em><span style="
 font-size:medium\;">Professor of Medicine and Pediatrics<br />Allergy &amp
 \; Immunology Program Director<br /><br /><br /></span></em></p><p style="
 text-align:center\;font-size:large\;"><strong>&ldquo\;What&rsquo\;s New in
  Antibiotic Allergies?&rdquo\;</strong></p><p style="text-align:left\;"><s
 trong>Objectives:</strong> At this conclusion of this presentation\, parti
 cipants should be able to:</p><ol style="text-align:center\;"><li style="t
 ext-align:left\;">Understand the morbidity associated with a penicillin al
 lergy label.</li><li style="text-align:left\;">Understand the low cross-re
 activity amongst beta-lactam antibiotics.</li><li style="text-align:left\;
 ">Be able to identify patients who are low risk\, and would be amenable to
  antibiotic delabeling.</li></ol><p>&nbsp\;</p><p style="text-align:left\;
 "><strong>Target Audience and Needs: </strong>Internal Medicine faculty\, 
 staff\, registered nurses\, residents\, fellows\, students\, and internist
 s specializing in Allergy &amp\; Immunology\, Cardiology\, Endocrinology\,
  Gastroenterology\, General Medicine\,\n    Geriatrics\, Hematology &amp\;
  Oncology\, Infectious Diseases\, Nephrology\, Palliative Care\, Pulmonary
  Critical Care &amp\; Sleep Medicine\, and Rheumatology need to be regular
 ly updated with new research and guidelines regarding the evaluation\n    
 and management of medical disorders and implement them in clinical practic
 e to enhance the quality of patient care and improve patient outcomes.</p>
 <p style="text-align:left\;"><strong>Educational Methods: </strong>Educati
 onal methods will include lectures\, case presentations\, literature revie
 w\, and panel discussion.</p><p style="text-align:left\;"><strong>Activity
  Evaluation: </strong>Participants may be asked to complete a session eval
 uation.</p><p style="text-align:left\;"><strong>Financial Disclosure: </st
 rong>The following are reports of relationships with commercial interests 
 by those individuals who are in the position to control the content of thi
 s activity.</p><p style="text-align:center\;"><strong>Dr. Khan does not ha
 ve any financial disclosures to provide.</strong></p><p style="text-align:
 center\;"><strong>&nbsp\;</strong></p><strong></strong><p style="text-alig
 n:left\;"><small>Accreditation/Credit Designation: </small><small>The Univ
 ersity of Texas Medical Branch is accredited by the Accreditation Council 
 for Continuing Medical Education (ACCME) to provide continuing medical edu
 cation for physicians.</small></p><small></small><p style="text-align:left
 \;"><small>The University of Texas Medical Branch designates this live act
 ivity for a maximum of _1_ AMA PRA Category 1 Credits&trade\;. Physicians 
 should claim only the credit commensurate with the extent of their partici
 pation in the activity.</small></p><strong></strong><p>&nbsp\;</p>
END:VEVENT
END:VCALENDAR